Literature DB >> 6633585

Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.

H L Levy, S E Waisbren.   

Abstract

We studied the effects of maternal phenylketonuria and hyperphenylalaninemia on 53 offspring from untreated pregnancies in 22 mothers who were identified by routine screening of umbilical-cord blood. The IQ of the offspring was significantly correlated with both maternal IQ (r = 0.83, P less than 0.001) and maternal blood phenylalanine level (r = 0.82, P less than 0.001), but with one exception, mental retardation in offspring was present only when the maternal blood phenylalanine level exceeded 1100 mumol per liter (18 mg per deciliter). Microcephaly in offspring was consistently present only when the maternal blood phenylalanine level exceeded 1200 mumol per liter (20 mg per deciliter). Congenital heart disease and other congenital anomalies were rare among offspring. The data suggest that severe atypical or classic phenylketonuria (blood phenylalanine level, greater than 1100 mumol per liter) in the mother has a substantial cognitive effect on her offspring but that the effect of mild hyperphenylalaninemia may have been overstated in the past.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6633585     DOI: 10.1056/NEJM198311243092101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

Review 1.  Undiagnosed phenylketonuria in adult women: a hidden public health problem.

Authors:  W B Hanley; J T Clarke; W E Schoonheyt
Journal:  CMAJ       Date:  1990-09-15       Impact factor: 8.262

2.  Maternal phenylketonuria.

Authors:  R Koch; E G Friedman; E Wenz; K Jew; C Crowley; G Donnell
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 3.  Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids.

Authors:  W M Pardridge
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 4.  Tetrahydrobipterin-responsive phenylalanine hydroxylase deficiency.

Authors:  Shigeo Kure; Haruo Shintaku
Journal:  J Hum Genet       Date:  2018-11-30       Impact factor: 3.172

Review 5.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

6.  Maternal phenylketonuria: comparison of two treated full term pregnancies.

Authors:  R P Soeters; R C Sengers; P W van Dongen; J M Trijbels; T K Eskes
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

7.  Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.

Authors:  S Kleiman; L Vanagaite; J Bernstein; G Schwartz; N Brand; A Elitzur; S L Woo; Y Shiloh
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

8.  A Chinese family with phenylketonuria and maternal phenylketonuria detected by family screening.

Authors:  K J Hsiao; C H Chen; P C Chiu; S C Huang; K D Wuu
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

9.  Maternal non-phenylketonuric mild hyperphenylalaninemia.

Authors:  H L Levy; S E Waisbren; D Lobbregt; E Allred; A Leviton; R Koch; W B Hanley; B Rouse; R Matalon; F de la Cruz
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

10.  The North American Maternal Phenylketonuria Collaborative Study, developmental assessment of the offspring: preliminary report.

Authors:  W B Hanley; R Koch; H L Levy; R Matalon; B Rouse; C Azen; F de la Cruz
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.